Micro Cap
Diagnostics & Research
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Exagen
XGN
$184M
| $184M | $7.60 | 0.65% |
|
|
IMDX
2
Insight Molecular Diagnostics
IMDX
$145M
| $145M | $4.44 | 2.78% |
|
|
QUCY
3
Quantum Cyber N.V.
QUCY
$114M
| $114M | $1.36 | 3.82% |
|
|
BNR
4
Burning Rock Biotech
BNR
$103M
| $103M | $9.80 | 5.04% |
|
5
MDxHealth
MDXH
$75.3M
| $75.3M | $0.7888 | 6.41% |
|
6
Precipio
PRPO
$55.2M
| $55.2M | $30.85 | 0.87% |
|
|
ADVB
7
Advanced Biomed Inc
ADVB
$15.2M
| $15.2M | $9.18 | 14.5% |
|
|
MBAI
8
Check-Cap
MBAI
$11.1M
| $11.1M | $8.08 | 0.5% |
|
9
American Shared Hospital Services
AMS
$9.78M
| $9.78M | $1.47 | 2.8% |
|
10
XWELL
XWEL
$8.68M
| $8.68M | $1.01 | 1% |
|
11
ENDRA Life Sciences
NDRA
$7.12M
| $7.12M | $4.75 | 4.17% |
|
12
VolitionRx Ltd
VNRX
$5.25M
| $5.25M | $0.3846 | 1.64% |
|
13
iSpecimen
ISPC
$4.03M
| $4.03M | $1.60 | 1.91% |
|
14
bioAffinity Technologies
BIAF
$2.8M
| $2.8M | $5.19 | 10.8% |
|
Micro Cap Diagnostics & Research Stocks at a Glance
Diagnostics and research companies run laboratory testing, imaging, and analytical services, and supply the instruments behind them. Testing volumes are recurring and largely non-discretionary, while research-tools demand follows pharma and academic R&D budgets.
There are 14 micro cap Diagnostics & Research stocks — companies in the Diagnostics & Research industry with a market cap under $250M — worth a combined $742M.
The largest by market cap are Exagen (XGN) at $184M, Insight Molecular Diagnostics (IMDX) at $145M and Quantum Cyber N.V. (QUCY) at $114M.
Among institutional investors, bioAffinity Technologies (BIAF) drew the most net new fund positions in Q2 2026: 9 funds opened new positions, taking total fund holders up 6 (50%) quarter-over-quarter.
- Combined market cap: $742M across 14 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Exagen (XGN), $184M market cap.
- Most net new fund positions in Q2 2026: bioAffinity Technologies (BIAF), +6 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.